BridgetFeyKoontzMDFASTRO

Summary

• Bridget Koontz MD FASTRO is a board-certified radiation oncologist. She trained at Harvard Medical School, University of North Carolina-Chapel Hill, and Duke University School of Medicine. In 2007 on completion of training she joined as faculty in the Department of Radiation Oncology, earning tenure as an Associate Professor and serving in several leadership roles. From 2021 to 2023, she was the US Chief Medical Officer for GenesisCare, a global oncology network and research organization. She now leads Radiation Oncology services at the AdventHealth Cancer Institute in Orlando Florida. Her interests are in promoting excellence of clinical care for patients with genitourinary malignancies and developing clinical and translational research to improve both the treatment of and recovery from cancer. She has frequently been faculty at national medical society meetings and has published over 100 articles, chapters, and books. She is the editor of the practical handbook Radiation Therapy Treatment Effects: An Evidence-Based Guide to Managing Toxicity. She has conducted translational laboratory research developing models of radiation-induced pelvic toxicity and is a recognized leader in clinical trials for prostate cancer. Her clinical focus is caring for patients with prostate, kidney, and bladder cancer.